Accepting new patients
Dr.
Dr Mark Henry Tuthill
Oncology
- 🇬🇧
- 🇫🇷
- GP consultation
- Annual physical exam
- Vaccination administration
- Minor procedure (skin)
About Dr Mark Henry Tuthill
Special clinical interest in breast, prostate, kidney and bladder cancer Dr Mark Tuthill is a Consultant Medical Oncologist who specialises in the treatment of early and recurrent cancers of the breast, prostate, kidney and bladder. In 2015, he was appointed Consultant Medical Oncologist at Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, where, in addition, he acts as Chief and Principal investigator on a number of clinical trials. Dr Tuthill focuses on providing a patient-centred approach to treatment ensuring clear communication, evidence-based therapies and molecularly targeted therapies to enable personalised medicine. Treatments can include the use of chemotherapy, hormone therapy, immunotherapy, or cancer growth inhibitors and experimental treatments given as part of clinical trials. Dr Tuthill originally qualified from University College London and trained in Medical Oncology in London. He holds a PhD in Tumour Immunology from Imperial College London and regularly presents his research at national and international conferences. Dr Tuthill is a clinical ambassador for UCARE (Urology Cancer Research and Education), an independent charity raising funds for research into prostate and bladder cancer and is a member of The Association of Cancer Physicians. Dr Tuthill's research interests include cancer vaccines, tumour immunology, cancer-growth inhibitors, and novel therapeutic drug combinations for the treatment of cancer. He is a Chief, principal investigator or sub-investigator for early and late phase clinical trials in tumour types including breast cancer, urological cancers and other tumour types. NHS Hospital • The Churchill Hospital • Oxford University Hospitals NHS Foundation Trust
"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."
Credentials & verification
Medical license
Organización Médica Colegial de España (OMC) ·
#-431417
Valid until 2028-12-31
Verify with issuerBoard certification
European Board of Oncology
#EB-BDEB251F
Renewal due 2032
Verify with issuerMalpractice cover
Allianz Professional
4,000,000 EUR
Valid until 2026-12-31
No claims on file
Education & training
-
2011–2017
MD · Medicine and Surgery
Universitat de Barcelona
-
2017–2021
Residency · Oncology
Universidad Complutense de Madrid
-
2021–2022
Fellowship · Subspecialty training
AP-HP Paris, FR
Career & appointments
-
2021-09–2022-08
Junior consultant
Universitat de Barcelona Teaching Hospital — Oncology
Procedures & conditions
| Procedure | Code | Lifetime volume |
|---|---|---|
| GP consultation | 99213 |
420 |
| Annual physical exam | 99395 |
138 |
| Vaccination administration | 90471 |
2,130 |
| Minor procedure (skin) | 17110 |
2,733 |
Patient reviews
See all 3"Very thorough first visit — explained every step. Booking was easy and the staff were welcoming."
"Took time to listen and reviewed all my previous results. I would absolutely recommend."
"Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent."
Recognition & press
Awards
- Top-rated Oncology — — EuroClinics Patient Choice · 2025 regional
- Excellence in Patient Care — National Society · 2024 national
Society memberships
- WONCA Europe — Family Doctors — Member · since 2022
- national college of family doctors — Member · since 2022
- European Union of Medical Specialists (UEMS) — Member · since 2022
Your consultation, step by step
- 1 Choose a slot
- 2 Brief pre-consult form
- 3 Consultation
- 4 Follow-up note & plan
Services & pricing
New patient consultation (60m)
Follow-up consultation (30m)
Vaccination administration
Minor procedure (skin)
Insurance compatibility
For international patients
Multilingual care
Coordinator: Patient liaison · dr.mark.tuthill.1@euroclinics.example. Care delivered in English · French.
Travel & transfer
Aftercare worldwide
Coordinated follow-up by request.
Research & publications
h-index: 13 · i10: 9
Selected publications
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.3729/euroclin.2025.0 · cited by 36
-
European registry analysis of Oncology outcomes
DOI: 10.3156/euroclin.2024.1 · cited by 38
Show full research record
Invited talks
- Practical updates in Oncology · European Annual Congress (Oncology) · Vienna · 2024
- Single-centre experience in Oncology · National Society Meeting · · 2023
Articles by Dr Mark Henry Tuthill
Frequently asked
01. Do you accept new patients?
Dr Mark Henry Tuthill is currently accepting new patients. Use the booking module to choose a slot.
02. Which languages can I be seen in?
Consultations are available in English, French.
03. Is the consultation in-person or online?
Most services are offered both in-clinic and via telemedicine. Each service card above marks its modalities.
04. Do you accept my insurance?
In-network with major international insurers (Allianz Worldwide, AXA Global, BUPA Global and others). Use the "Verify my insurance" button to confirm your plan.
05. What is the cancellation policy?
Free cancellation up to 24 hours before your slot. Last-minute cancellations may incur a small administrative fee.
06. How is my health data protected?
All records are stored on EU servers, field-level encrypted, and GDPR compliant. Data is never shared with third parties without your explicit consent.
Book Dr Mark Henry Tuthill
Similar Oncology specialists
Other verified specialists you may want to compare.